Compare DTIL & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DTIL | NATR |
|---|---|---|
| Founded | 2006 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.7M | 250.0M |
| IPO Year | 2019 | 1995 |
| Metric | DTIL | NATR |
|---|---|---|
| Price | $7.28 | $13.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $45.00 | $28.33 |
| AVG Volume (30 Days) | ★ 260.1K | 236.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.00 |
| EPS | N/A | ★ 0.48 |
| Revenue | ★ $1,070,000,000.00 | $480,144,000.00 |
| Revenue This Year | N/A | $7.76 |
| Revenue Next Year | N/A | $4.82 |
| P/E Ratio | ★ N/A | $29.50 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $3.53 | $12.97 |
| 52 Week High | $9.62 | $28.14 |
| Indicator | DTIL | NATR |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 27.62 |
| Support Level | $7.18 | $13.72 |
| Resistance Level | $7.92 | $21.27 |
| Average True Range (ATR) | 0.46 | 0.40 |
| MACD | -0.10 | 0.15 |
| Stochastic Oscillator | 9.52 | 31.58 |
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.